NCT05018767View on ClinicalTrials.gov

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty

PHASE1RecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

January 22, 2022

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
Frailty
Interventions
BIOLOGICAL

AlloRx

cultured allogeneic adult umbilical cord derived mesenchymal stem cells

Trial Locations (3)

1000

RECRUITING

Artros, Ljubljana

16675

RECRUITING

Athens Beverly Hills Medical Group, Glyfada

Unknown

RECRUITING

Medical Surgical Associates Center, St John's

All Listed Sponsors
lead

The Foundation for Orthopaedics and Regenerative Medicine

OTHER